Modeus, the leader in electronic controlled medication management software, today announced a strategic partnership with New Zealand-based healthcare software provider, ReCare. This partnership allows DDBook to be integrated with ReCare pharmacy software, and will make the Medsafe-approved DDBook Cloud system available to the entire New Zealand pharmacy market, just in time for the 30 December physical audit requirements.
Following a successful launch and integration with RxOne and formal approval from Medsafe in September, Modeus is rapidly expanding its footprint to help all NZ pharmacies streamline compliance, enhance safety, and eliminate paper-based controlled drug (CD) registers.
A Complete Digital Solution for NZ Pharmacies
The new partnership and integration provides a comprehensive, fully digital solution for the management of controlled drugs.
Modeus’ DDBook Cloud is a cloud-based electronic controlled drug register that replaces traditional paper-based registers in the pharmacy. It provides real-time recording, full audit trails, and automatic updates, significantly improving accuracy, governance, and efficiency. Automating daily line entries and stock counts, it frees up pharmacists’ time and ensures all records are secure, compliant, and backed up at all times.
ReCare provides innovative software solutions for healthcare professionals in Australia and New Zealand, dedicated to improving patient outcomes through proactive and automated workflows. ReCare’s platform is designed to seamlessly integrate with pharmacy workflow to protect patients, increase engagement, and grow revenue through tools like automated patient communication, prescription notifications (nudge), and integrated clinical services (EarlyCare).
“Securing Medsafe approval and launching with RxOne was just the beginning,” said Carl Zufi, CEO of Modeus. “Our new partnership with ReCare, and the immediate integration with NZ pharmacy, means that our gold-standard compliance solution is now accessible to every pharmacy across the country. We are thrilled to work alongside ReCare to bring greater efficiency and safety to the New Zealand health sector.”
Grant Bai, Director of ReCare, added, “ReCare is focused on empowering pharmacists with innovative, integrated tools. The addition of Modeus’ DDBook Cloud to our ecosystem offers a critical piece of the digital puzzle, ensuring that the management of controlled medicines is as simple and safe as possible for our customers. This collaboration marks a significant step forward for pharmacy efficiency and patient care in New Zealand.”
Key Milestones Achieved
September 2025: Medsafe granted formal approval to the DDBook Cloud System as an Approved Recording System for controlled drugs (Approval No.: RI22480016-00), confirming its compliance with the Misuse of Drugs Regulations 1977.
Successful Launch: Initial launch with RxOne resulted in strong uptake, demonstrating the immediate value and ease of adoption for New Zealand pharmacists.
National Availability: The new partnership with ReCare ensures that the digital controlled drug register is now a viable option for all pharmacies in the market, regardless of their dispensing software.
About Modeus Modeus is a leading provider of electronic controlled drug management software across pharmacy, hospital, aged care, veterinary, warehouses, and other health sectors. With over 22 years of industry experience, Modeus solutions, including DDBook, are trusted to promote accountability, ensure compliance, and enhance safety in medication management.
About ReCare ReCare is an innovative software company in Australia and New Zealand dedicated to improving patient outcomes by providing healthcare professionals with innovative software solutions. Their unique platform automates patient communication while building HCP-patient engagement and outcomes, fully integrated with pharmacy.